MECP2 and schizophrenia: Mutations in the methyl CpG binding protein 2 gene (MECP2) have been shown to lead to neurodevelopmental deficits, such as those associated with Rett syndrome [4], and aberrant DNA methylation signatures have been observed in several neuropsychiatric disorders, including schizophrenia and bipolar disorder [5].